FDA Approved: IMBRUVICA — Original Application (Pharmacyclics LLC)

View source ↗

Summary

The FDA approved the original application for IMBRUVICA (ibrutinib) from Pharmacyclics LLC, establishing its initial approval for mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)

Snippet

ORIG AP for IMBRUVICA (IBRUTINIB)